O
Opto Bio
Health Tech & Medtech · Cambridge, United Kingdom · Founded 2022
Developing technology that improves the lives of people suffering from neurological disorders MoreLess
Opto Biosystems is at the forefront of revolutionizing the treatment of neurological disorders through the development of cutting-edge, minimally invasive implants. The company serves a diverse range of clients including clinicians, researchers, and therapy providers, operating primarily in the medical technology and healthcare markets. Opto Biosystems' business model is centered around extensive research, development, and clinical testing to create safe and effective biological interfacing solutions. Revenue is generated through partnerships, clinical collaborations, and the commercialization of their proprietary implant technologies. The company is committed to improving patient outcomes and advancing the frontiers of medical science.
Keywords: neurological disorders, minimally invasive, implants, biological interfacing, medical technology, healthcare, clinical testing, patient outcomes, research, development.
Company overview
Opto Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2022
- Headquarters
- Cambridge, United Kingdom
- Employees
- 14
- Open positions
- 1
- Dealroom signal
- 64.4
Valuation & funding
Opto Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Nov 2025 | $10M | $40M | Blackbird Ventures · Linhao Zhang · Tim Shi · Focalpoint Ventures | ↗ |
| GRANTOther financing | May 2025 | $951K | — | UK Research and Innovation | — |
| SEEDOther financing | Mar 2023 | $2.5M | $10M | Blackbird Ventures | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 14 |
| 2025 | 18 |
| 2024 | 11 |
| 2023 | 8 |
Growth signals
Opto Bio website traffic
Latest recorded traffic for Opto Bio is 7.3K monthly website visits, up 21.7% over the last three months. Opto Bio's team declined 22.2% over the past year.
Hiring
Open positions at Opto Bio
Current openings linked to this company in Dealroom.
Comparisons
Opto Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Opto Bio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Opto Bio has talent and traffic
team presence
In the news
Latest news about Opto Bio
Recent press, funding announcements, and product moves mentioning Opto Bio — open to read from the original sources.
Market sentiment
What the market is saying about Opto Bio
An AI-synthesized read of the highest-engagement posts about Opto Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Opto Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.